TOP CATEGORY: Chemicals & Materials | Life Sciences | Banking & Finance | ICT Media

  1. Home
  2. purchase Customization

purchase customization

Leave This Empty:

choose chapter to purchase


Back to Report

table of content

Table of Contents
1 Research Methodology and Statistical Scope
1.1 Market Definition and Statistical Scope of Gene-based Therapy Medicinal
1.2 Key Market Segments
1.2.1 Gene-based Therapy Medicinal Segment by Type
1.2.2 Gene-based Therapy Medicinal Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 Gene-based Therapy Medicinal Market Overview
2.1 Global Market Overview
2.1.1 Global Gene-based Therapy Medicinal Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Gene-based Therapy Medicinal Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 Gene-based Therapy Medicinal Market Competitive Landscape
3.1 Global Gene-based Therapy Medicinal Sales by Manufacturers (2019-2024)
3.2 Global Gene-based Therapy Medicinal Revenue Market Share by Manufacturers (2019-2024)
3.3 Gene-based Therapy Medicinal Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Gene-based Therapy Medicinal Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Gene-based Therapy Medicinal Sales Sites, Area Served, Product Type
3.6 Gene-based Therapy Medicinal Market Competitive Situation and Trends
3.6.1 Gene-based Therapy Medicinal Market Concentration Rate
3.6.2 Global 5 and 10 Largest Gene-based Therapy Medicinal Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 Gene-based Therapy Medicinal Industry Chain Analysis
4.1 Gene-based Therapy Medicinal Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 The Development and Dynamics of Gene-based Therapy Medicinal Market
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 Gene-based Therapy Medicinal Market Segmentation by Type
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Gene-based Therapy Medicinal Sales Market Share by Type (2019-2024)
6.3 Global Gene-based Therapy Medicinal Market Size Market Share by Type (2019-2024)
6.4 Global Gene-based Therapy Medicinal Price by Type (2019-2024)
7 Gene-based Therapy Medicinal Market Segmentation by Application
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Gene-based Therapy Medicinal Market Sales by Application (2019-2024)
7.3 Global Gene-based Therapy Medicinal Market Size (M USD) by Application (2019-2024)
7.4 Global Gene-based Therapy Medicinal Sales Growth Rate by Application (2019-2024)
8 Gene-based Therapy Medicinal Market Segmentation by Region
8.1 Global Gene-based Therapy Medicinal Sales by Region
8.1.1 Global Gene-based Therapy Medicinal Sales by Region
8.1.2 Global Gene-based Therapy Medicinal Sales Market Share by Region
8.2 North America
8.2.1 North America Gene-based Therapy Medicinal Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Gene-based Therapy Medicinal Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Gene-based Therapy Medicinal Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Gene-based Therapy Medicinal Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Gene-based Therapy Medicinal Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 Key Companies Profile
9.1 Biogen
9.1.1 Biogen Gene-based Therapy Medicinal Basic Information
9.1.2 Biogen Gene-based Therapy Medicinal Product Overview
9.1.3 Biogen Gene-based Therapy Medicinal Product Market Performance
9.1.4 Biogen Business Overview
9.1.5 Biogen Gene-based Therapy Medicinal SWOT Analysis
9.1.6 Biogen Recent Developments
9.2 Novartis
9.2.1 Novartis Gene-based Therapy Medicinal Basic Information
9.2.2 Novartis Gene-based Therapy Medicinal Product Overview
9.2.3 Novartis Gene-based Therapy Medicinal Product Market Performance
9.2.4 Novartis Business Overview
9.2.5 Novartis Gene-based Therapy Medicinal SWOT Analysis
9.2.6 Novartis Recent Developments
9.3 Gilead Sciences
9.3.1 Gilead Sciences Gene-based Therapy Medicinal Basic Information
9.3.2 Gilead Sciences Gene-based Therapy Medicinal Product Overview
9.3.3 Gilead Sciences Gene-based Therapy Medicinal Product Market Performance
9.3.4 Gilead Sciences Gene-based Therapy Medicinal SWOT Analysis
9.3.5 Gilead Sciences Business Overview
9.3.6 Gilead Sciences Recent Developments
9.4 Sarepta Therapeutics
9.4.1 Sarepta Therapeutics Gene-based Therapy Medicinal Basic Information
9.4.2 Sarepta Therapeutics Gene-based Therapy Medicinal Product Overview
9.4.3 Sarepta Therapeutics Gene-based Therapy Medicinal Product Market Performance
9.4.4 Sarepta Therapeutics Business Overview
9.4.5 Sarepta Therapeutics Recent Developments
9.5 Alnylam Pharmaceuticals
9.5.1 Alnylam Pharmaceuticals Gene-based Therapy Medicinal Basic Information
9.5.2 Alnylam Pharmaceuticals Gene-based Therapy Medicinal Product Overview
9.5.3 Alnylam Pharmaceuticals Gene-based Therapy Medicinal Product Market Performance
9.5.4 Alnylam Pharmaceuticals Business Overview
9.5.5 Alnylam Pharmaceuticals Recent Developments
9.6 Amgen
9.6.1 Amgen Gene-based Therapy Medicinal Basic Information
9.6.2 Amgen Gene-based Therapy Medicinal Product Overview
9.6.3 Amgen Gene-based Therapy Medicinal Product Market Performance
9.6.4 Amgen Business Overview
9.6.5 Amgen Recent Developments
9.7 Spark Therapeutics
9.7.1 Spark Therapeutics Gene-based Therapy Medicinal Basic Information
9.7.2 Spark Therapeutics Gene-based Therapy Medicinal Product Overview
9.7.3 Spark Therapeutics Gene-based Therapy Medicinal Product Market Performance
9.7.4 Spark Therapeutics Business Overview
9.7.5 Spark Therapeutics Recent Developments
9.8 Akcea Therapeutics
9.8.1 Akcea Therapeutics Gene-based Therapy Medicinal Basic Information
9.8.2 Akcea Therapeutics Gene-based Therapy Medicinal Product Overview
9.8.3 Akcea Therapeutics Gene-based Therapy Medicinal Product Market Performance
9.8.4 Akcea Therapeutics Business Overview
9.8.5 Akcea Therapeutics Recent Developments
9.9 Sunway Biotech
9.9.1 Sunway Biotech Gene-based Therapy Medicinal Basic Information
9.9.2 Sunway Biotech Gene-based Therapy Medicinal Product Overview
9.9.3 Sunway Biotech Gene-based Therapy Medicinal Product Market Performance
9.9.4 Sunway Biotech Business Overview
9.9.5 Sunway Biotech Recent Developments
9.10 SIBIONO
9.10.1 SIBIONO Gene-based Therapy Medicinal Basic Information
9.10.2 SIBIONO Gene-based Therapy Medicinal Product Overview
9.10.3 SIBIONO Gene-based Therapy Medicinal Product Market Performance
9.10.4 SIBIONO Business Overview
9.10.5 SIBIONO Recent Developments
9.11 AnGes
9.11.1 AnGes Gene-based Therapy Medicinal Basic Information
9.11.2 AnGes Gene-based Therapy Medicinal Product Overview
9.11.3 AnGes Gene-based Therapy Medicinal Product Market Performance
9.11.4 AnGes Business Overview
9.11.5 AnGes Recent Developments
9.12 Orchard Therapeutics
9.12.1 Orchard Therapeutics Gene-based Therapy Medicinal Basic Information
9.12.2 Orchard Therapeutics Gene-based Therapy Medicinal Product Overview
9.12.3 Orchard Therapeutics Gene-based Therapy Medicinal Product Market Performance
9.12.4 Orchard Therapeutics Business Overview
9.12.5 Orchard Therapeutics Recent Developments
9.13 Human Stem Cells Institute
9.13.1 Human Stem Cells Institute Gene-based Therapy Medicinal Basic Information
9.13.2 Human Stem Cells Institute Gene-based Therapy Medicinal Product Overview
9.13.3 Human Stem Cells Institute Gene-based Therapy Medicinal Product Market Performance
9.13.4 Human Stem Cells Institute Business Overview
9.13.5 Human Stem Cells Institute Recent Developments
10 Gene-based Therapy Medicinal Market Forecast by Region
10.1 Global Gene-based Therapy Medicinal Market Size Forecast
10.2 Global Gene-based Therapy Medicinal Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Gene-based Therapy Medicinal Market Size Forecast by Country
10.2.3 Asia Pacific Gene-based Therapy Medicinal Market Size Forecast by Region
10.2.4 South America Gene-based Therapy Medicinal Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Gene-based Therapy Medicinal by Country
11 Forecast Market by Type and by Application (2025-2030)
11.1 Global Gene-based Therapy Medicinal Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Gene-based Therapy Medicinal by Type (2025-2030)
11.1.2 Global Gene-based Therapy Medicinal Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Gene-based Therapy Medicinal by Type (2025-2030)
11.2 Global Gene-based Therapy Medicinal Market Forecast by Application (2025-2030)
11.2.1 Global Gene-based Therapy Medicinal Sales (Kilotons) Forecast by Application
11.2.2 Global Gene-based Therapy Medicinal Market Size (M USD) Forecast by Application (2025-2030)
12 Conclusion and Key Findings